Blood clots in acute coronary syndrome
Drug discovery / Therapeutics
Acute coronary syndrome (ACS) is the term for any sudden reduction in the blood flow to the heart. It is the cause of thousands of deaths and hospitalisations in the UK each year.
Despite current treatments, recurrence of cardiovascular events in those who survive ACS is common.
This study aims to explore novel therapies that may harness the body’s natural clot busting mechanism.
This will provide greater insight into why blood clots form in the body, as well as highlighting potential treatment options to prevent it from happening again.
The development of a new AI-supported model for imaging the heart based on data from over 700 people with atrial fibrillation, allow ablation to be more personalised to individual patients.
A trial for every patient
Personalised angina care
Developing an AI-assisted computer programme to identify whether a conduction system pacing (CSP) procedure has been successful, which will allow more patients to benefit from this innovative pacemaker technology.
Your gifts fund our life saving project